Moreover, RORα expression inversely correlates with G6PD and PFKFB3, and low RORα combined with high G6PD or PFKFB3 predicts poor survival in gastric cancer, indicating RORα as a potential biomarker and therapeutic target [7]. The gene discussed is G6PD; the disease is gastric cancer.